Related Experiment Video
Updated: Jan 25, 2026
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Triptolide Inhibits Breast Cancer Cell Metastasis Through Inducing the Expression of miR-146a, a Negative Regulator
Qin Liu1, Wei Wang2, Fangqiong Li2
1Department of Blood Transfusion, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
Abstract:
Triptolide, an extract of Tripterygium wilfordii, has been shown to have a potent anticancer activity. In the present study, it was found that triptolide could effectively induce apoptosis and inhibit proliferation and invasion in malignant MDA-MB-231 breast cancer cells. The study focused on its effect on inhibiting invasion, which has not been extensively reported to date. We predicted that triptolide may change invasion activity via microRNAs (miRNAs), which have been recognized as important regulators of gene expression. miRNAome variation in MDA-MB-231 cells with or without triptolide treatment demonstrated that miR-146a was upregulated following treatment with triptolide. Our previous studies have shown that miR-146a can inhibit migration and invasion by targeting RhoA in breast cancer. This time, we found that miR-146a can target Rac1, another key member of the Rho GTPase family. Luciferase reporter containing Rac1 3'-UTR was constructed to prove this hypothesis. In addition, following treatment with triptolide, the expression of RhoA and Rac1 was found to be decreased. These results indicated that triptolide exerts its anti-invasion activity through a miRNA-mediated mechanism, which indirectly regulates the expression of Rho GTPase. Triptolide combined with miR-146a could improve the effect of triptolide treatment on breast cancer.
Insights
Triptolide, derived from Tripterygium wilfordii, inhibits breast cancer cell invasion. This anticancer compound upregulates miR-146a, which targets Rho GTPases like Rac1, reducing invasion and improving treatment effects.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Triptolide, an extract from Tripterygium wilfordii, exhibits potent anticancer properties.
- Its effects on inhibiting cancer cell invasion, particularly in breast cancer, require further elucidation.
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer progression.
Purpose of the Study:
- To investigate the anti-invasion mechanisms of triptolide in MDA-MB-231 breast cancer cells.
- To explore the role of microRNAs in mediating triptolide's anti-invasion effects.
- To identify specific molecular targets of triptolide-regulated miRNAs involved in invasion.
Main Methods:
- Analysis of miRNAome variation in MDA-MB-231 cells treated with triptolide.
- Validation of miR-146a targeting of Rac1 using a luciferase reporter assay.
- Quantification of RhoA and Rac1 expression levels following triptolide treatment.
Main Results:
- Triptolide treatment upregulated miR-146a expression in MDA-MB-231 cells.
- miR-146a was confirmed to target Rac1, a Rho GTPase family member.
- Triptolide treatment decreased the expression of RhoA and Rac1, inhibiting cell invasion.
Conclusions:
- Triptolide inhibits breast cancer cell invasion through a miRNA-mediated mechanism.
- The study identifies a novel pathway involving miR-146a targeting Rac1 and RhoA.
- Combining triptolide with miR-146a may enhance therapeutic effects against breast cancer.
Related Concept Videos
02:14GTPases and their Regulation
Large G-proteins,...
02:14GTPases and their Regulation
01:24Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
01:23Negative Regulator Molecules
02:24Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
01:21Cell Polarization by Rho Proteins